Media

In a new white paper issued today, BIO updates the results of a study of the greenhouse gas emissions resulting from EPA's proposal to reduce biofuel use...
BIO is pleased to announce the creation of the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology to be presented to an outstanding...

Press Releases

Dec 7 1999
WASHINGTON, D.C. (Dec. 7, 1999) -- The Biotechnology Industry Organization (BIO) will present alternatives to proposed guidelines for reporting adverse patient...
Dec 6 1999
(Carl Feldbaum, president of BIO, today issued the following statement upon the death of Bob Swanson, co-founder of Genentech): Washington, D.C. (December 6,...
Nov 24 1999
(Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement prior to the start of the World Trade Organization's...
Nov 23 1999
See Senate Resolution 200 below WASHINGTON, D.C. (Nov. 23, 1999) -- The Biotechnology Industry Organization (BIO) applauds the U.S. Senate for its adoption of...
Nov 22 1999
WASHINGTON, D.C. (Nov. 22, 1999) -- Included in the 2000 budget legislation passed by Congress are three measures that give a major boost to the biotechnology...
Nov 18 1999
The Biotechnology Industry Organization (BIO) is pleased to be invited by the Food and Drug Administration (FDA) to participate on the Food Safety Panel for...
Nov 18 1999
Thank you for inviting the Biotechnology Industry Organization (BIO) to provide a statement on the Food and Drug Administration's policy on information issues...
Nov 16 1999
WASHINGTON, D.C. (Nov. 16, 1999) -- The Biotechnology Industry Organization (BIO) fully concurs with the U.S. Food and Drug Administration's (FDA) initiative...
Nov 16 1999
WASHINGTON, D.C. -- (Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement in advance of the Food and Drug...


Biotechnology News

October 24, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its third quarter financial results and business update on Thursday, November...

October 24, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that the Company...

October 24, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck LLC announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New...

October 24, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) will be represented at the American College of Emergency Physicians (ACEP) Annual Scientific...

October 24, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jim Hindman,...